Mary E. Huff

688 total citations
8 papers, 578 citations indexed

About

Mary E. Huff is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Mary E. Huff has authored 8 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Cell Biology. Recurrent topics in Mary E. Huff's work include Alzheimer's disease research and treatments (6 papers), Cellular transport and secretion (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). Mary E. Huff is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Cellular transport and secretion (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). Mary E. Huff collaborates with scholars based in United States and United Kingdom. Mary E. Huff's co-authors include Jeffery W. Kelly, William E. Balch, Evan T. Powers, Gayathri Ratnaswamy, Lesley J. Page, Albert Eschenmoser, Richard A. Lerner, Paul Wentworth, Jan Bieschke and Jorge J. Nieva and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Journal of Molecular Biology.

In The Last Decade

Mary E. Huff

8 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Huff United States 8 362 190 132 89 59 8 578
Riccardo Porcari United Kingdom 14 613 1.7× 270 1.4× 87 0.7× 69 0.8× 19 0.3× 17 779
Timothy W. Rhoads United States 13 445 1.2× 182 1.0× 112 0.8× 51 0.6× 15 0.3× 17 783
Leonardo M. Cortez Canada 13 320 0.9× 137 0.7× 67 0.5× 108 1.2× 29 0.5× 29 542
Pinaki Misra United States 11 314 0.9× 139 0.7× 67 0.5× 35 0.4× 21 0.4× 24 446
Shiori Tamamizu‐Kato United States 6 480 1.3× 385 2.0× 66 0.5× 26 0.3× 33 0.6× 6 760
Jung‐Hoon Kang South Korea 13 208 0.6× 46 0.2× 117 0.9× 17 0.2× 39 0.7× 25 521
S Narindrasorasak Canada 12 615 1.7× 372 2.0× 34 0.3× 215 2.4× 61 1.0× 17 811
Jeffrey A. Cohlberg United States 12 555 1.5× 265 1.4× 294 2.2× 430 4.8× 16 0.3× 18 1.1k
King Faisal Yambire Germany 8 382 1.1× 159 0.8× 62 0.5× 94 1.1× 19 0.3× 9 690
Devin S. Iimoto United States 10 195 0.5× 169 0.9× 24 0.2× 71 0.8× 25 0.4× 13 471

Countries citing papers authored by Mary E. Huff

Since Specialization
Citations

This map shows the geographic impact of Mary E. Huff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Huff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Huff more than expected).

Fields of papers citing papers by Mary E. Huff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Huff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Huff. The network helps show where Mary E. Huff may publish in the future.

Co-authorship network of co-authors of Mary E. Huff

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Huff. A scholar is included among the top collaborators of Mary E. Huff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Huff. Mary E. Huff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Page, Lesley J., Mary E. Huff, Hee‐Jong Lim, et al.. (2005). Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. The EMBO Journal. 24(23). 4124–4132. 52 indexed citations
2.
Page, Lesley J., Mary E. Huff, Jeffery W. Kelly, & William E. Balch. (2004). Ca2+ binding protects against gelsolin amyloidosis. Biochemical and Biophysical Research Communications. 322(4). 1105–1110. 8 indexed citations
3.
Zhang, Qinghai, Evan T. Powers, Jorge J. Nieva, et al.. (2004). Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proceedings of the National Academy of Sciences. 101(14). 4752–4757. 167 indexed citations
4.
Huff, Mary E., Lesley J. Page, William E. Balch, & Jeffery W. Kelly. (2003). Gelsolin Domain 2 Ca2+ Affinity Determines Susceptibility to Furin Proteolysis and Familial Amyloidosis of Finnish Type. Journal of Molecular Biology. 334(1). 119–127. 26 indexed citations
5.
Huff, Mary E., William E. Balch, & Jeffery W. Kelly. (2003). Pathological and functional amyloid formation orchestrated by the secretory pathway. Current Opinion in Structural Biology. 13(6). 674–682. 58 indexed citations
6.
DiDonato, Michael, Lisa Craig, Mary E. Huff, et al.. (2003). ALS Mutants of Human Superoxide Dismutase Form Fibrous Aggregates Via Framework Destabilization. Journal of Molecular Biology. 332(3). 601–615. 172 indexed citations
7.
Ratnaswamy, Gayathri, et al.. (2001). Destabilization of Ca2+-free gelsolin may not be responsible for proteolysis in Familial Amyloidosis of Finnish Type. Proceedings of the National Academy of Sciences. 98(5). 2334–2339. 21 indexed citations
8.
Koepf, Edward K., H. Michael Petrassi, Gayathri Ratnaswamy, et al.. (1999). Characterization of the Structure and Function of W → F WW Domain Variants:  Identification of a Natively Unfolded Protein That Folds upon Ligand Binding. Biochemistry. 38(43). 14338–14351. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026